Melbourne, Victoria, Australia.
+61 3 8559 6530
Subscribe
Email Us
Home
About Us
Research
Governance Committee
Resources
Publications
MRV Newsletters
MRV Consumers
Clare Oliver
Donate
About Melanoma
All Melanoma News
For Patients
About Melanoma
MRV Consumers
Australian Melanoma Skin Cancer Alliance (AMSCA)
MRV Newsletters
Events
For Researchers
Collaborate Now
Resources
MRV Cohort
Clinical Data
MRV Biospecimens
Quality of Life Data
Follow Up Data
MRV Research Projects
Working with Consumers
Melanoma News
Events
Contact Us
Collaborate Now
Merck’s Investigational Anti-PD1 Antibody, MK-3475, Active in Three Different Tumor Types: New Data to be Presented at the 2014 ASCO Annual Meeting
Please read the attached press release for more information
Menu
